New Study Demonstrates Improvements in Lupus Patients Receiving Stem Cell Therapies

Lupus study shows promising results using umbilical cord mesenchymal stem cells. NANJING, Jiangsu, China, June 7, 2010 /PRNewswire-Asia/ — A new study shows that umbilical cord mesenchymal stem cell transplant…

Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease

Beike Biotechnology Co., Ltd. today announced that a team led by Dr. Yang Xiaofeng at its collaborating hospital in Shenyang completed a study to assess clinical efficacy, safety, and feasibility…

Beike Biotechnology Founder Sean Hu: Scientist CEO With a Universal Healthcare Dream

Beike Biotechnology Founder Sean Hu: Scientist CEO With a Universal Healthcare Dream

In a recent interview in the Beike Biotechnology headquarters in Shenzhen, Dr. Sean Hu shared his thoughts on the current situation of Beike and the field of cell therapy. He…

Shenzhen Integrated Cell Bank is Preparing for AABB Accreditation

Shenzhen Integrated Cell Bank is Preparing for AABB Accreditation

In January of 2017 Beike Biotechnology held a meeting with local officials and the international accreditation center to prepare the Shenzhen Integrated Cell Bank for American Association of Blood Bank…

“e-Dura,” Another Spinal Cord Injury Breakthrough

“e-Dura,” Another Spinal Cord Injury Breakthrough

2014 was undeniably a great year for spinal cord injury breakthroughs, and it seems 2015 is off to a strong start as well. These new SCI breakthroughs are truly ushering…

Beike Biotechnology’s Shenzhen Facility Earns AABB Accreditation

Beike Biotechnology’s Shenzhen Facility Earns AABB Accreditation

Shenzhen, China – Beike Biotechnology has been granted AABB accreditation for cord blood processing, storage, distribution, cell therapy activity (MSC, cord blood; MSC, placenta; NC, whole blood), somatic cell processing,…


1 2 8 9